TBX1 and cancer: CAFs have pro-tumor properties by stimulating the growth and survival of cancer cells, inducing the migration of other cells to the TME, especially immune cells and cells involved in angiogenesis, modulating the innate and acquired immune response, and regulating metabolic activity in the TME and cancer cell mobility [4,5,8,9,10,11].